Skip to main content
Erschienen in: Medical Microbiology and Immunology 3/2003

01.08.2003 | Original Investigation

Pathogenesis of Adamantiades-Behçet's disease

verfasst von: Christos C. Zouboulis, Tobias May

Erschienen in: Medical Microbiology and Immunology | Ausgabe 3/2003

Einloggen, um Zugang zu erhalten

Abstract

The aetiology of Adamantiades-Behçet's disease remains unknown and its pathogenesis is not fully understood. Linked intrinsic and extrinsic factors are thought to contribute to the development of the disease, which probably occurs by environmental triggering of a genetically determined disorder. Transmission is solely vertical, indicating that the disease is not contagious. Genetic factors have been investigated and a significant link of HLA-B51, especially of HLA-B5101, has been identified. However, none of the functional correlates of the disease appear to be restricted by HLA-B51. Recently, the role of the genes encoding TNF, Tap proteins and MICA has been emphasised. Extrinsic pathogenetic candidates have been identified, including bacterial (Streptococcus sanguis, Mycoplasma fermentas) and viral (human herpes virus) antigens and environmental pollution, which may cross-react with oral mucosal antigens and induce immunological mechanisms. A common factor linking some of the possible pathogenetic agents is extrinsically induced tissue stress or heat shock proteins, which react with host tissues and elicit significant Th1 cell responses. Neutrophils may also play a role in the pathogenesis of the disease, as they are attracted by macrophages and activated endothelial cells, which release cytokines and chemokines (especially IL-8) at the site of the lesions, and thus contribute to tissue damage and self maintenance of inflammation. Endothelial activation leading to a chronic local inflammation process together with platelet and serum factors enhance coagulation and thrombosis.
Literatur
1.
2.
Zurück zum Zitat Zouboulis CC (1999) Epidemiology of Adamantiades-Behçet's disease. Ann Med Intern 150:488–498 Zouboulis CC (1999) Epidemiology of Adamantiades-Behçet's disease. Ann Med Intern 150:488–498
3.
Zurück zum Zitat Zouboulis CC, Kötter I, Djawari D, et al (1997) Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 38:411–422PubMed Zouboulis CC, Kötter I, Djawari D, et al (1997) Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 38:411–422PubMed
4.
Zurück zum Zitat Stewart JAB (1986) Genetic analysis of families with Behçet's syndrome: data incompatible with autosomal recessive inheritence. Ann Rheum Dis 45:265–268PubMed Stewart JAB (1986) Genetic analysis of families with Behçet's syndrome: data incompatible with autosomal recessive inheritence. Ann Rheum Dis 45:265–268PubMed
5.
Zurück zum Zitat Fresko I, Soy M, Hamuryudan V, et al (1998) Genetic anticipation in Behçet's disease. Ann Rheum Dis 57:45–48PubMed Fresko I, Soy M, Hamuryudan V, et al (1998) Genetic anticipation in Behçet's disease. Ann Rheum Dis 57:45–48PubMed
6.
Zurück zum Zitat Falk K, Rötzschke O, Takiguchi M, et al (1995) Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behçet's disease. Int Immunol 7:223–228PubMed Falk K, Rötzschke O, Takiguchi M, et al (1995) Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behçet's disease. Int Immunol 7:223–228PubMed
7.
Zurück zum Zitat Mizuki N, Ohno SH, Sato T, et al (1995) Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. Hum Immunol 43:129–135CrossRefPubMed Mizuki N, Ohno SH, Sato T, et al (1995) Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. Hum Immunol 43:129–135CrossRefPubMed
8.
Zurück zum Zitat Kötter I, Günaydin I, Stübiger N, et al (2001) Comparative analysis of the association of HLA-B*51x and its suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens 58:166–170CrossRefPubMed Kötter I, Günaydin I, Stübiger N, et al (2001) Comparative analysis of the association of HLA-B*51x and its suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens 58:166–170CrossRefPubMed
9.
Zurück zum Zitat Ota M, Mizuki N, Katsuyama Y, et al (1999) The critical region for Behçet disease in the human MHC is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 64:1406–1410CrossRefPubMed Ota M, Mizuki N, Katsuyama Y, et al (1999) The critical region for Behçet disease in the human MHC is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 64:1406–1410CrossRefPubMed
10.
Zurück zum Zitat Mizuki N, Ota M, Yabuki K, et al (2000) Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 41:3702–3708 Mizuki N, Ota M, Yabuki K, et al (2000) Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 41:3702–3708
11.
Zurück zum Zitat Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Behçet's disease. Semin Arthritis Rheum 27:197–217 Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Behçet's disease. Semin Arthritis Rheum 27:197–217
12.
Zurück zum Zitat Mizuki N, Ota M, Kimura M, et al (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proc Natl Acad Sci USA 94:1298–1303PubMed Mizuki N, Ota M, Kimura M, et al (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proc Natl Acad Sci USA 94:1298–1303PubMed
13.
Zurück zum Zitat Adamantiades B (1931) Sur un cas d'iritis à hypopion récidivant. Ann Ocul (Paris) 168:271–278 Adamantiades B (1931) Sur un cas d'iritis à hypopion récidivant. Ann Ocul (Paris) 168:271–278
14.
Zurück zum Zitat Mizushima Y, Matsuda T, Hoshi K, Ohno S (1988) Induction of Behçet's disease symptoms following dental treatment and streptococcal antigen skin test. J Rheumatol 15:1029–1030PubMed Mizushima Y, Matsuda T, Hoshi K, Ohno S (1988) Induction of Behçet's disease symptoms following dental treatment and streptococcal antigen skin test. J Rheumatol 15:1029–1030PubMed
15.
Zurück zum Zitat Hoover CI, Greenspan JS (1983) Immunochemical comparison of cell-wall antigens of various viridans streptococci, including strain 2A2+3 hot from recurrent oral aphthous ulceration in man. Arch Oral Biol 28:917–922PubMed Hoover CI, Greenspan JS (1983) Immunochemical comparison of cell-wall antigens of various viridans streptococci, including strain 2A2+3 hot from recurrent oral aphthous ulceration in man. Arch Oral Biol 28:917–922PubMed
16.
Zurück zum Zitat Namba K, Uena T, Okito M (1986) Behçet's disease and streptococcal infection. Int J Ophthalmol 30:385–401 Namba K, Uena T, Okito M (1986) Behçet's disease and streptococcal infection. Int J Ophthalmol 30:385–401
17.
Zurück zum Zitat Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y (1995) Streptococcus oralis previously identified as uncommon "Streptococcus sanguis" in Behçet's disease. Arch Oral Biol 40:685–690CrossRefPubMed Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y (1995) Streptococcus oralis previously identified as uncommon "Streptococcus sanguis" in Behçet's disease. Arch Oral Biol 40:685–690CrossRefPubMed
18.
Zurück zum Zitat Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 14:21PubMed Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 14:21PubMed
19.
Zurück zum Zitat Kaneko F, Takahashi Y, Muramatsu Y (1985) Immunological studies an aphthous ulcer and erythema nodosum like eruptions in Behçet's disease. Br J Dermatol 113:303–312PubMed Kaneko F, Takahashi Y, Muramatsu Y (1985) Immunological studies an aphthous ulcer and erythema nodosum like eruptions in Behçet's disease. Br J Dermatol 113:303–312PubMed
20.
Zurück zum Zitat Yokota K, Oguma K (1997) IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behçet's disease. Microbiol Immunol 41:925–931PubMed Yokota K, Oguma K (1997) IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behçet's disease. Microbiol Immunol 41:925–931PubMed
21.
Zurück zum Zitat Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fujii N (1998) Cloning and sequencing of BeS-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behçet's disease. Zentralbl Bakteriol 287:449–460PubMed Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fujii N (1998) Cloning and sequencing of BeS-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behçet's disease. Zentralbl Bakteriol 287:449–460PubMed
22.
Zurück zum Zitat Zouboulis CC, Turnbull JR, Mühlradt PF (in press) High seroprevalenceof anti-Mycoplasma fermentans antibodies in patients with Adamantiades-Behçet's disease. J Invest Dermatol Zouboulis CC, Turnbull JR, Mühlradt PF (in press) High seroprevalenceof anti-Mycoplasma fermentans antibodies in patients with Adamantiades-Behçet's disease. J Invest Dermatol
23.
Zurück zum Zitat Calcutt MJ, Kim MF, Karpas AB, Mühlradt PF, Wise KS (1999) Differential post-translational processing confers intraspecies variation of a major surface lipoprotein and macrophage-activating lipopeptide (MALP-2) of Mycoplasma fermentans. Infect Immun 67:760–771PubMed Calcutt MJ, Kim MF, Karpas AB, Mühlradt PF, Wise KS (1999) Differential post-translational processing confers intraspecies variation of a major surface lipoprotein and macrophage-activating lipopeptide (MALP-2) of Mycoplasma fermentans. Infect Immun 67:760–771PubMed
24.
Zurück zum Zitat Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis CC (in press) Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis CC (in press) Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology
25.
Zurück zum Zitat Behçet H (1937) Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152–1157 Behçet H (1937) Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152–1157
26.
Zurück zum Zitat Eglin RP, Lehner T (1982) Detection of RNA complementary herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulceration. Lancet II:1356–360 Eglin RP, Lehner T (1982) Detection of RNA complementary herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulceration. Lancet II:1356–360
27.
Zurück zum Zitat Studd M, McCauce DJ, Lehner T (1991) Detection of HSV 1 DNA in patients with Behçet's syndrome in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 34:39–43PubMed Studd M, McCauce DJ, Lehner T (1991) Detection of HSV 1 DNA in patients with Behçet's syndrome in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 34:39–43PubMed
28.
Zurück zum Zitat Lee S, Bang D, Cho YH, Lee ES, Sohn S (1996) Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease. Arch Dermatol Res 288:179–183 Lee S, Bang D, Cho YH, Lee ES, Sohn S (1996) Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease. Arch Dermatol Res 288:179–183
29.
Zurück zum Zitat Hamzaoui K, Ayed K, Slim A (1990) Natural killer cell activity, interferon gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol 79:28–30 Hamzaoui K, Ayed K, Slim A (1990) Natural killer cell activity, interferon gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol 79:28–30
30.
Zurück zum Zitat Gnodratnamo F, Riggio MP, Way D (1997) Search for human herpes virus 6, human cytomegalovirus and varicella zoster virus DNA in recurrent aphthous stomatitis tissue. J Oral Pathol Med 26:192–197PubMed Gnodratnamo F, Riggio MP, Way D (1997) Search for human herpes virus 6, human cytomegalovirus and varicella zoster virus DNA in recurrent aphthous stomatitis tissue. J Oral Pathol Med 26:192–197PubMed
31.
Zurück zum Zitat Münke H, Stöckmann F, Ramadori G (1995) Possible association between Behçet's syndrome and chronic hepatitis C virus infection. N Engl J Med 332:400–401CrossRef Münke H, Stöckmann F, Ramadori G (1995) Possible association between Behçet's syndrome and chronic hepatitis C virus infection. N Engl J Med 332:400–401CrossRef
32.
Zurück zum Zitat Ilter N, Senol E, Gurer MA, Öztas M (2000) Behçet's disease and HCV infection. Int J Dermatol 39:396–397 Ilter N, Senol E, Gurer MA, Öztas M (2000) Behçet's disease and HCV infection. Int J Dermatol 39:396–397
33.
Zurück zum Zitat Cantini F, Emmi L, Niccoli L, Padula A, Salvarani C, Olivieri I (1997) Lack of association between chronic hepatitis C virus infection and Behçet's disease. Clin Exp Rheumatol :15:338–339 Cantini F, Emmi L, Niccoli L, Padula A, Salvarani C, Olivieri I (1997) Lack of association between chronic hepatitis C virus infection and Behçet's disease. Clin Exp Rheumatol :15:338–339
34.
Zurück zum Zitat Ishikawa S, Miyata M, Fujiwara N, et al (1977) Experimental "muco-cutaneo-entero-genital syndrome" in pedigreed miniature swine (toxicologic study). In: Dilsen N, Konice M, Ovül C (eds) Behçet's disease. Proceedings of the 2nd International Symposium on Behçet's Disease. Elsevier, Amsterdam, pp 53–59 Ishikawa S, Miyata M, Fujiwara N, et al (1977) Experimental "muco-cutaneo-entero-genital syndrome" in pedigreed miniature swine (toxicologic study). In: Dilsen N, Konice M, Ovül C (eds) Behçet's disease. Proceedings of the 2nd International Symposium on Behçet's Disease. Elsevier, Amsterdam, pp 53–59
35.
Zurück zum Zitat Hori Y, Miyazawa S, Nishiyama S, Miyata M, Ishikawa S (1979) Experimental Behçet's disease and ultrastructural X-ray microanalysis of pathological tissues. J Dermatol. 6:31–37 Hori Y, Miyazawa S, Nishiyama S, Miyata M, Ishikawa S (1979) Experimental Behçet's disease and ultrastructural X-ray microanalysis of pathological tissues. J Dermatol. 6:31–37
36.
Zurück zum Zitat Lehner T (1999) Immunopathogenesis of Behçet's disease. Ann Med Interne (Paris) 150:483–487 Lehner T (1999) Immunopathogenesis of Behçet's disease. Ann Med Interne (Paris) 150:483–487
37.
Zurück zum Zitat Jindal S, Dudani AK, Singh B, Harley CB, Gupta RS (1989) Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaparonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol 9:2279–2283 Jindal S, Dudani AK, Singh B, Harley CB, Gupta RS (1989) Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaparonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol 9:2279–2283
38.
Zurück zum Zitat Pervin K, Childerstone A, Shinnick T, et al (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 151:2273–2282PubMed Pervin K, Childerstone A, Shinnick T, et al (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 151:2273–2282PubMed
39.
Zurück zum Zitat Hasan A, Fortune F, Wilson A, et al (1996) Role of γδT cells in pathogenesis and diagnosis of Behçet's disease. Lancet 347:789–794PubMed Hasan A, Fortune F, Wilson A, et al (1996) Role of γδT cells in pathogenesis and diagnosis of Behçet's disease. Lancet 347:789–794PubMed
40.
Zurück zum Zitat Lehner T, Lavery E, Smith R, Zee R van der, Mizushima Y, Shinnick T (1991) Association between the 65-kDa heat shock protein, "Streptococcus sanguis" and the corresponding antibodies in Behçet's syndrome. Infect Immun 59:1434–1441PubMed Lehner T, Lavery E, Smith R, Zee R van der, Mizushima Y, Shinnick T (1991) Association between the 65-kDa heat shock protein, "Streptococcus sanguis" and the corresponding antibodies in Behçet's syndrome. Infect Immun 59:1434–1441PubMed
41.
Zurück zum Zitat Kaneko S, Suzuki N, Yamashita N, et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108:204–212 Kaneko S, Suzuki N, Yamashita N, et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108:204–212
42.
Zurück zum Zitat Tasçi B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock proteins (hsp) 65 in the cerebrospinal fluid of neuro-Behçet's patients. Clin Exp Immunol 113:100–104 Tasçi B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock proteins (hsp) 65 in the cerebrospinal fluid of neuro-Behçet's patients. Clin Exp Immunol 113:100–104
43.
Zurück zum Zitat Lehner T (1967) Behçet's syndrome and autoimmunity. Br Med J 1:465–467PubMed Lehner T (1967) Behçet's syndrome and autoimmunity. Br Med J 1:465–467PubMed
44.
45.
Zurück zum Zitat Steinle A, Groh V, Spies T (1998) Diversification, expression, and γδT cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. Proc Natl Acad Sci USA 95:12510–12515CrossRefPubMed Steinle A, Groh V, Spies T (1998) Diversification, expression, and γδT cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. Proc Natl Acad Sci USA 95:12510–12515CrossRefPubMed
46.
Zurück zum Zitat Zouboulis CC (1995) Morbus Adamantiades-Behçet: Klinische und experimentelle Untersuchungen—Erhebungen an 53 Patienten aus dem Berliner Raum. Habilitationsschrift, Fachbereich Humanmedizin der Freien Universität Berlin, Berlin Zouboulis CC (1995) Morbus Adamantiades-Behçet: Klinische und experimentelle Untersuchungen—Erhebungen an 53 Patienten aus dem Berliner Raum. Habilitationsschrift, Fachbereich Humanmedizin der Freien Universität Berlin, Berlin
47.
Zurück zum Zitat Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R (1996) Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 55:128–133PubMed Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R (1996) Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 55:128–133PubMed
48.
Zurück zum Zitat Takeno M, Kariyone A, Yamashita N, et al (1995) Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 38:426–433PubMed Takeno M, Kariyone A, Yamashita N, et al (1995) Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 38:426–433PubMed
49.
Zurück zum Zitat Sakane T (1997) New perspective in Behçet's disease. Int Rev Immunol 14:89–96PubMed Sakane T (1997) New perspective in Behçet's disease. Int Rev Immunol 14:89–96PubMed
50.
Zurück zum Zitat Rizzi R, Bruno S, Dammacco R (1997) Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 27:225–232 Rizzi R, Bruno S, Dammacco R (1997) Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 27:225–232
51.
Zurück zum Zitat Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T (1996) Monocyte activity in Behçet's disease. Br J Rheumatol 35:424–429PubMed Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T (1996) Monocyte activity in Behçet's disease. Br J Rheumatol 35:424–429PubMed
52.
Zurück zum Zitat Zouboulis CC, Katsantonis J, Ketteler R, et al (2000) Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279–284 Zouboulis CC, Katsantonis J, Ketteler R, et al (2000) Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279–284
53.
Zurück zum Zitat Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC (2000) Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than c-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39CrossRefPubMed Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC (2000) Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than c-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39CrossRefPubMed
54.
Zurück zum Zitat Wang R, Chuang CY, Chen CY (1992) Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro Behçet's syndrome. Clin Exp Rheumatol 10:599–602PubMed Wang R, Chuang CY, Chen CY (1992) Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro Behçet's syndrome. Clin Exp Rheumatol 10:599–602PubMed
55.
Zurück zum Zitat Akoglu T, Direskeneli H, Yazici H, Lawrence R (1990) TNF, soluble IL-2R and soluble CD8 in Behçet's disease. J Rheumatol 17:1107–1108PubMed Akoglu T, Direskeneli H, Yazici H, Lawrence R (1990) TNF, soluble IL-2R and soluble CD8 in Behçet's disease. J Rheumatol 17:1107–1108PubMed
56.
Zurück zum Zitat Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM (1997) Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24:128–132PubMed Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM (1997) Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24:128–132PubMed
57.
Zurück zum Zitat Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967–1974CrossRefPubMed Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967–1974CrossRefPubMed
58.
Zurück zum Zitat Kienbaum S, Zouboulis CC, Waibel M, Orfanos CE (1993) Chemotactic neutrophilic vasculitis: a new histopathological pattern of vasculitis found in mucocutaneous lesions of patients with Adamantiades-Behçet's disease. In: Wechsler B, Godeau P (eds) Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam, pp 337–341 Kienbaum S, Zouboulis CC, Waibel M, Orfanos CE (1993) Chemotactic neutrophilic vasculitis: a new histopathological pattern of vasculitis found in mucocutaneous lesions of patients with Adamantiades-Behçet's disease. In: Wechsler B, Godeau P (eds) Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam, pp 337–341
59.
Zurück zum Zitat Treudler R, Zouboulis CC, Büttner P, Detmar M, Orfanos CE (1996) Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet's disease. Arch Dermatol 132:1323–1329PubMed Treudler R, Zouboulis CC, Büttner P, Detmar M, Orfanos CE (1996) Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet's disease. Arch Dermatol 132:1323–1329PubMed
60.
Zurück zum Zitat Hamzaoui K, Ayed K, Hamza M, Touraine JL (1988) Natural killer cells in Behçet's disease. Clin Exp Immunol 71:126–131PubMed Hamzaoui K, Ayed K, Hamza M, Touraine JL (1988) Natural killer cells in Behçet's disease. Clin Exp Immunol 71:126–131PubMed
61.
Zurück zum Zitat Önder M, Bozkurt M, Gürer MA, Gulekon A, Sezgin P, Imir T (1994) Natural cellular cytotoxicity in Behçet's disease. J Dermatol 21:239–243PubMed Önder M, Bozkurt M, Gürer MA, Gulekon A, Sezgin P, Imir T (1994) Natural cellular cytotoxicity in Behçet's disease. J Dermatol 21:239–243PubMed
62.
Zurück zum Zitat Bozkurt M, Gürer MA, Gulekon A, Keskin N, Ercan S (1989) Arachidonic acid metabolites in Behçet's disease. Int J Dermatol 28:141–142PubMed Bozkurt M, Gürer MA, Gulekon A, Keskin N, Ercan S (1989) Arachidonic acid metabolites in Behçet's disease. Int J Dermatol 28:141–142PubMed
63.
Zurück zum Zitat Lee KH, Chung HS, Bang D, Lee S (1999) Behçet's disease sera containing anti-endothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells. Yonsei Med J 40:152–158PubMed Lee KH, Chung HS, Bang D, Lee S (1999) Behçet's disease sera containing anti-endothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells. Yonsei Med J 40:152–158PubMed
64.
Zurück zum Zitat Kansu E, Sahin G, Sahin F, Sivri B, Sayek I, Batman F (1986) Impaired prostacyclin synthesis by vessel walls in Behçet's disease. Lancet II:1154 Kansu E, Sahin G, Sahin F, Sivri B, Sayek I, Batman F (1986) Impaired prostacyclin synthesis by vessel walls in Behçet's disease. Lancet II:1154
65.
Zurück zum Zitat Örem A, Cimsit G, Deger O (1999) Auto antibodies against oxidatively modified low density lipoprotein in patients with Behçet's disease. Dermatology 198:243–246CrossRefPubMed Örem A, Cimsit G, Deger O (1999) Auto antibodies against oxidatively modified low density lipoprotein in patients with Behçet's disease. Dermatology 198:243–246CrossRefPubMed
66.
Zurück zum Zitat Lee KH, Bang D, Choi ES, Chun WH, Lee ES, Lee S (1999) Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease. Arch Dermatol Res 291:374–381 Lee KH, Bang D, Choi ES, Chun WH, Lee ES, Lee S (1999) Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease. Arch Dermatol Res 291:374–381
67.
Zurück zum Zitat Triolo G, Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Giardina E (1999) Enhancement of endothelial cell E-selection expression by sera from patients with active Behçet's disease:moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 91:330–337PubMed Triolo G, Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Giardina E (1999) Enhancement of endothelial cell E-selection expression by sera from patients with active Behçet's disease:moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 91:330–337PubMed
68.
Zurück zum Zitat Kim YC, Bang D, Lee S, Lee KH (2000) The effect of herpesvirus infection on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells. J Dermatol Sci 24:38–47CrossRefPubMed Kim YC, Bang D, Lee S, Lee KH (2000) The effect of herpesvirus infection on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells. J Dermatol Sci 24:38–47CrossRefPubMed
69.
Zurück zum Zitat Zouboulis CC, Büttner P, Tebbe B, Orfanos CE (1993) Anticardiolipin antibodies in Adamantiades-Behçet's disease. Br J Dermatol 128:281–284PubMed Zouboulis CC, Büttner P, Tebbe B, Orfanos CE (1993) Anticardiolipin antibodies in Adamantiades-Behçet's disease. Br J Dermatol 128:281–284PubMed
70.
Zurück zum Zitat Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M (1982) Auto-oxidative damage in Behçet's disease—endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247–255PubMed Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M (1982) Auto-oxidative damage in Behçet's disease—endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247–255PubMed
71.
Zurück zum Zitat Espinosa G, Font J, Tassies D, et al (2002) Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112:37–43PubMed Espinosa G, Font J, Tassies D, et al (2002) Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112:37–43PubMed
72.
Zurück zum Zitat Uslu T, Erem C, Tosun M, Deger O (1997) Plasma endothelin-1 levels in Behçet's disease. Clin Rheumatol 16:59–61PubMed Uslu T, Erem C, Tosun M, Deger O (1997) Plasma endothelin-1 levels in Behçet's disease. Clin Rheumatol 16:59–61PubMed
73.
Zurück zum Zitat Haznedaroglu IC, Özdemir O, Özcebe O, Dündar SV, Kirazli S (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 75:974–975PubMed Haznedaroglu IC, Özdemir O, Özcebe O, Dündar SV, Kirazli S (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 75:974–975PubMed
Metadaten
Titel
Pathogenesis of Adamantiades-Behçet's disease
verfasst von
Christos C. Zouboulis
Tobias May
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
Medical Microbiology and Immunology / Ausgabe 3/2003
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-002-0167-5

Weitere Artikel der Ausgabe 3/2003

Medical Microbiology and Immunology 3/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.